Radiotheranostics Market Size, Share & COVID-19 Impact Analysis, By Radioisotopes (Lutetium-177, Radium-223, Iodine-131, and Others), By Application (Neuroendocrine Tumors, Prostate Cancer, and Others), By End-user (Hospitals & Clinics, Diagnostic Centers, and Others), and Regional Forecast, 2023-2030

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI108932

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2019-2021
Growth Rate	CAGR of 18.5% from 2023 to 2030
Unit	Value (USD Billion)
Segmentation	By Radioisotopes Lutetium-177 Radium-223 Iodine-131 Others
	By Application Neuroendocrine Tumors Prostate Cancer Others
	By End-user Hospitals & Clinics Diagnostic Centers Others
	By Region North America (By Radioisotopes, Application, End-user, and Country) U.S. Canada Europe (By Radioisotopes, Application, End-user, and Country) U.K. Germany France Italy Spain Rest of Europe Asia Pacific (By Radioisotopes, Application, End-user, and Country) China Japan India Australia Rest of Asia Pacific Rest of the World (By Radioisotopes, Application, and End-user)